Your browser doesn't support javascript.
loading
Traditional and Novel Adiposity Indicators and Pancreatic Cancer Risk: Findings from the UK Women's Cohort Study.
Shyam, Sangeetha; Greenwood, Darren; Mai, Chun-Wai; Tan, Seok Shin; Mohd Yusof, Barakatun Nisak; Moy, Foong Ming; Cade, Janet.
Afiliação
  • Shyam S; Division of Nutrition and Dietetics, School of Health Sciences, International Medical University (IMU), Kuala Lumpur 57000, Malaysia.
  • Greenwood D; Centre for Translational Research, IMU Institute for Research, Development and Innovation (IRDI), Kuala Lumpur 57000, Malaysia.
  • Mai CW; School of Medicine, University of Leeds, Leeds LS2 9LN, UK.
  • Tan SS; Leeds Institute for Data Analytics, University of Leeds, Leeds LS2 9LN, UK.
  • Mohd Yusof BN; Centre for Cancer and Stem Cells Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur 57000, Malaysia.
  • Moy FM; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Cade J; Division of Nutrition and Dietetics, School of Health Sciences, International Medical University (IMU), Kuala Lumpur 57000, Malaysia.
Cancers (Basel) ; 13(5)2021 Mar 02.
Article em En | MEDLINE | ID: mdl-33801191
ABSTRACT
(1)

Background:

We studied the association of both conventional (BMI, waist and hip circumference and waist-hip ratio) and novel (UK clothing sizes) obesity indices with pancreatic cancer risk in the UK women's cohort study (UKWCS). (2)

Methods:

The UKWCS recruited 35,792 women from England, Wales and Scotland from 1995 to 1998. Cancer diagnosis and death information were obtained from the National Health Service (NHS) Central Register. Cox's proportional hazards regression was used to evaluate the association between baseline obesity indicators and pancreatic cancer risk. (3)

Results:

This analysis included 35,364 participants with a median follow-up of 19.3 years. During the 654,566 person-years follow up, there were 136 incident pancreatic cancer cases. After adjustments for age, smoking, education and physical activity, each centimetre increase in hip circumference (HR 1.03, 95% CI 1.01-1.05, p = 0.009) and each size increase in skirt size (HR 1.12, 95% CI 1.02-1.23, p = 0.041) at baseline increased pancreatic cancer risk. Baseline BMI became a significant predictor of pancreatic cancer risk (HR 1.04, 95% CI 1.00-1.08, p = 0.050) when latent pancreatic cancer cases were removed. Only baseline hip circumference was associated with pancreatic cancer risk (HR 1.03, 95% CI 1.00-1.05, p = 0.017) when participants with diabetes at baseline were excluded to control for reverse causality. (4)

Conclusion:

Hip circumference and skirt size were significant predictors of pancreatic cancer risk in the primary analysis. Thus, hip circumference is useful to assess body shape relationships. Additionally, standard skirt sizes offer an economical and objective alternative to conventional obesity indices for evaluating pancreatic cancer risk in women.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Malásia País de publicação: CH / SUIZA / SUÍÇA / SWITZERLAND

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Malásia País de publicação: CH / SUIZA / SUÍÇA / SWITZERLAND